Is a
Person attributes
Founder of
Prior to the founding of Scribe Therapeutics Brett Staahl worked as a Postdoctoral Fellow in the Doudna Lab at UC Berkeley on the research of CRISPR ribonucleoproteins, developing precise in vivo and ex vivo protein-to-cell delivery methods for the safe inactivation of disease-causing genes and slowing of neurodegeneration.
Timeline
No Timeline data yet.
Current Employer
Patents
Further Resources
No Further Resources data yet.
